KOVINA THERAPEUTICS INC — Federal Contracts, Awards & Government Contractor Profile

About KOVINA THERAPEUTICS INC

Kovina Therapeutics is a preclinical stage biotechnology company developing targeted antiviral therapeutics designed to eliminate Human Papillomavirus (HPV) driven cancers and premalignant infections caused by HPV. The company focuses on first-in-class small molecules that target the HPV E6 oncogene to treat a full spectrum of HPV-related diseases.

Development of first-in-class small molecule antiviralsTargeting the HPV E6 oncogene to selectively kill HPV-infected cellsTriggering apoptosis in infected cells while sparing healthy tissueTreating the full spectrum of HPV disease, from premalignant infections to invasive cancers

Is this your company?

Claim KOVINA THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim KOVINA THERAPEUTICS INC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.